Cargando…
Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer
BACKGROUND: Previous studies showing an association between chronic use of proton pump inhibitor (PPI) and gastric cancer are limited by confounding by indication. This relationship has not been studied in patients receiving PPI for prophylaxis, such as those undergoing percutaneous coronary interve...
Autores principales: | Ng, Andrew Kei-Yan, Ng, Pauline Yeung, Ip, April, Cheung, Ka-Shing, Siu, Chung-Wah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359470/ https://www.ncbi.nlm.nih.gov/pubmed/34380699 http://dx.doi.org/10.1136/bmjgast-2021-000719 |
Ejemplares similares
-
The putative role of ferroptosis in gastric cancer: a review
por: Wang, Li, et al.
Publicado: (2023) -
Deep learning in gastric tissue diseases: a systematic review
por: Gonçalves, Wanderson Gonçalves e, et al.
Publicado: (2020) -
Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
por: Chang, Alex Yuang-Chi, et al.
Publicado: (2016) -
Profiling of gastric cancer cell-surface markers to achieve tumour–normal discrimination
por: Toh, Judith, et al.
Publicado: (2020) -
Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials
por: Manzini, Giulia, et al.
Publicado: (2017)